Back
Viavi Solutions 10K Form
Sell
40
VIAV
Viavi Solutions
Last Price:
$10.95
Seasonality Move:
3.59%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-03 | 10Q | VIAV/Viavi Solutions Quarterly |
2023-05-03 | 10Q | VIAV/Viavi Solutions Quarterly |
2023-02-03 | 10Q | VIAV/Viavi Solutions Quarterly |
2022-11-04 | 10Q | VIAV/Viavi Solutions Quarterly |
2022-05-05 | 10Q | VIAV/Viavi Solutions Quarterly |
2022-02-07 | 10Q | VIAV/Viavi Solutions Quarterly |
Receive VIAV News And Ratings
See the #1 stock for the next 7 days that we like better than VIAV
VIAV Financial Statistics
Sales & Book Value
Annual Sales: | $1B |
---|---|
Cash Flow: | $36.5M |
Price / Cash Flow: | 29.99 |
Annual Sales: | $3.07 |
Price / Book: | 3.56 |
Profitability
EPS (TTM): | -0.18000 |
---|---|
Net Income (TTM): | $-39M |
Gross Margin: | $575.9M |
Return on Equity: | -5.57% |
Return on Assets: | -2.22% |
Viavi Solutions Earnings Forecast
Key Viavi Solutions Financial Ratios
-
The Gross Profit Margin over the past 33 years for VIAV is 57.57%.
-
The Selling, General & Administrative Expenses for VIAV have been equal to 33.32% of Gross Profit Margin.
-
The Research & Development expenses have been 20.18% of Revenue.
-
The Net Earning history of VIAV is -2.58% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 17 years.
Viavi Solutions Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Communications Equipment |
Sector: | Information Technology |
Current Symbol: | VIAV |
CUSIP: | 925550 |
Website: | viavisolutions.com |
Debt
Debt-to-Equity Ratio: | 0.94 |
---|---|
Current Ratio: | 3.55 |
Quick Ratio: | 3.01 |
Price-to-Earnings
Trailing P/E Ratio: | 72 |
---|---|
Forward P/E Ratio: | 19.85 |
VIAV Technical Analysis vs Fundamental Analysis
Sell
40
Viavi Solutions (VIAV)
is a Sell
Is Viavi Solutions a Buy or a Sell?
-
Viavi Solutions stock is rated a SellThe current Viavi Solutions [VIAV] share price is $10.94. The Score for VIAV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.